These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8967765)

  • 21. Emerging infectious diseases: new and resistant strains of HIV.
    Paul SM; Costa SJ; Cross H; Pierce M; Pizutti W; Morgan DH; Ziskin LZ
    N J Med; 1997 Jun; 94(6):43-7. PubMed ID: 9195842
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA approves urine-based Western blot test for HIV. Food and Drug Administration.
    AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update: HIV-2 infection among blood and plasma donors--United States, June 1992-June 1995.
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):407-9. PubMed ID: 11361466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home screening kit for HIV approved.
    AORN J; 1996 Oct; 64(4):587. PubMed ID: 8967770
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA approves first viral-load test. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):94. PubMed ID: 11363657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasenstive PCR approved.
    Proj Inf Perspect; 1999 Apr; (27):20. PubMed ID: 11366736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA approves ViroSeq HIV-1 genotyping system.
    Expert Rev Mol Diagn; 2003 Jan; 3(1):6. PubMed ID: 12528357
    [No Abstract]   [Full Text] [Related]  

  • 28. New rapid HIV test.
    AIDS Patient Care STDS; 2003 Apr; 17(4):204-5. PubMed ID: 12751541
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved HIV viral load test approved by the FDA.
    Expert Rev Mol Diagn; 2002 Sep; 2(5):401. PubMed ID: 12271810
    [No Abstract]   [Full Text] [Related]  

  • 30. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of HIV antigen and cDNA among antibody-negative blood samples in Nigeria.
    Odaibo GN; Taiwo A; Aken'Ova YA; Olaleye DO
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):284-7. PubMed ID: 18243259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic methods for HIV infections].
    Szczepanek A; Płucienniczak A
    Postepy Hig Med Dosw; 1994; 48(4):325-44. PubMed ID: 7638088
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic acid amplification testing detection of an HIV-1 infection in a blood donor during the preseroconversion window period.
    Piquet Y; Ivanovic Z; Laperche S; Pillonel J; Cristol G; Jeanne M; Neau D; Fleury H; Boiron JM
    Transfus Med; 2007 Apr; 17(2):147-8. PubMed ID: 17430474
    [No Abstract]   [Full Text] [Related]  

  • 36. Roche HIV-1 PCR-based blood screening assay cleared for marketing in Italy.
    Expert Rev Mol Diagn; 2002 May; 2(3):203. PubMed ID: 12050856
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 antibody testing.
    Jean JH
    Del Med J; 1997 Mar; 69(3):156. PubMed ID: 9110510
    [No Abstract]   [Full Text] [Related]  

  • 39. Performance evaluation programs for determining HIV-1 viral loads, testing for HIV p24 antigen, and identifying Mycobacterium tuberculosis using nucleic acid amplification tests.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(7):155-6. PubMed ID: 9072675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 and HCV infections among antibody-negative blood donors.
    Begovac J; Mihaljevic I; Perrin L
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15548785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.